European Cancer Organisation: Time To Act

OncoAlert and ecancer weekly roundup for April 19 - 25, 2021

SMMART Program: A multi-omics tumour board with a focus on breast cancer

PC14586: The first orally bioavailable small molecule reactivator of Y220C mutant p53 in clinical development

Adjuvant therapy with nivolumab combined with ipilimumab vs nivolumab alone in patients with resected stage IIIB-D/IV melanoma

Clinical validation of a targeted methylation-based multi-cancer early detection test

Efficacy and safety of selpercatinib in RET fusion-positive cancers other than lung or thyroid cancers

Assessing comprehensive score for financial toxicity (COST) among radiation oncology patients in India

Autologous tumour infiltrating lymphocytes cell therapy in metastatic non-small cell lung cancer

Highlights from AORTIC Cancer Genomics Conference 2021

Real world data and diagnostics in patients with NSCLC with EGFR exon 20 insertions

Durvalumab following radiotherapy in patients with unresectable, stage 3 NSCLC ineligible for chemotherapy